Clinical Trial Update: Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure [Phase 1]

View source ↗

Summary

Phase 1 study of M2ES in patients with advanced pancreatic cancer after gemcitabine failure. The entry provides a trial status update with no results reported t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• M2ES

Snippet

Sponsor: Protgen Ltd | Conditions: Pancreatic Cancer | Phase 1 | Status: UNKNOWN